Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The study is a multicenter, Phase 1, open-label, sequential, adaptive, single dose, PK/PD study in subjects with moderate and severe RI and healthy volunteers (HV).
Epistemonikos ID: 328c412b0f26638159665ba4c0a014358916737e
First added on: May 13, 2024